Skip to content

Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3 (LRIT3)

Homo sapiens — UniProt Q3SXY7

Gene: LRIT3Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3 (LRIT3) is a protein from Homo sapiens identified by UniProt accession Q3SXY7, 679 residues long. MolForge cross-references it against 0 known binders and 38 disease associations.

  • UniProt accession: Q3SXY7; gene symbol LRIT3.
  • Organism: Homo sapiens.
  • Length: 679 amino acids.
  • Top disease associations (Open Targets): congenital stationary night blindness, Stargardt disease and body height.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameLeucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3
UniProt accessionQ3SXY7
GeneLRIT3
OrganismHomo sapiens
Length679 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (38)

Diseases linked to this target (Open Targets).

  • congenital stationary night blindness · score 0.65
  • Stargardt disease · score 0.43
  • body height · score 0.39
  • body weight · score 0.27
  • lean body mass · score 0.25
  • genetic disorder · score 0.19
  • fat body mass · score 0.19
  • whole body water mass · score 0.12
  • base metabolic rate measurement · score 0.10
  • platelet count · score 0.05

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q3SXY7-F1alphafoldPREDICTED69.64—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q3SXY7.

Amino-acid sequence (679 residues)

MHLFACLCIV LSFLEGVGCL CPSQCTCDYH GRNDGSGSRL VLCNDMDMNE LPTNLPVDTV KLRIEKTVIR RISAEAFYYL VELQYLWVTY NSVASIDPSS FYNLKQLHEL RLDGNSLAAF PWASLLDMPL LRTLDLHNNK ITSVPNEALR YLKNLAYLDL SSNRLTTLPP DFLESWTHLV STPSGVLDLS PSRIILGLQD NPWFCDCHIS KMIELSKVVD PAIVLLDPLM TCSEPERLTG ILFQRAELEH CLKPSVMTSA TKIMSALGSN VLLRCDATGF PTPQITWTRS DSSPVNYTVI QESPEEGVRW SIMSLTGISS KDAGDYKCKA KNLAGMSEAV VTVTVLGITT TPIPPDTSER TGDHPEWDVQ PGSGRSTSVS SASSYLWSSS FSPTSSFSAS TLSPPSTASF SLSPFSSSTV SSTTTLSTSI SASTTMANKR SFQLHQGGKR NLKVAKNGSK LPPASTSKKE ELALLDQTML TETNAAIENL RVVSETKESV TLTWNMINTT HNSAVTVLYS KYGGKDLLLL NADSSKNQVT IDGLEPGGQY MACVCPKGVP PQKDQCITFS TERVEGDDSQ WSLLLVVTST ACVVILPLIC FLLYKVCKLQ CKSEPFWEDD LAKETYIQFE TLFPRSQSVG ELWTRSHRDD SEKLLLCSRS SVESQVTFKS EGSRPEYYC

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with LRIT3?

The strongest Open Targets associations for LRIT3 are congenital stationary night blindness, Stargardt disease, body height, body weight and lean body mass.

How long is the LRIT3 protein?

The Homo sapiens LRIT3 protein (UniProt Q3SXY7) is 679 amino acids long.

Browse: Targets: L · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ3SXY7
GeneLRIT3
OrganismHomo sapiens
Length679
Binders0
Diseases38
View on UniProt